Stockholm Medical Cannabis Conference

Is CBD effective against more than indications than paediatric epilepsies? – What does the clinical evidence tell us?

In this blog post, we provide a summary of a recent review article published in the Journal of Cannabis Research by O’Sullivan et al. on June 13th. The review focuses on the use of purified CBD products in clinical studies to determine potential indications for which purified CBD could be beneficial. While the findings suggest that purified CBD can be effective in various conditions beyond epilepsy, the evidence base is limited due to trials primarily investigating acute effects, trials conducted on healthy volunteers, and trials with small patient populations. To establish the efficacy of purified CBD across different indications, large confirmatory phase 3 trials are necessary. Join us as we delve into the therapeutic benefits of purified CBD for various conditions based on randomized controlled trials and explore the strengths and weaknesses of the review.

Beyond the High: Unraveling Non-GPCR Targets in the eCBome

Delve into the lesser-known facets of the endocannabinoid system (eCBome), focusing on non-GPCR targets like FAAH, MAGL, DAGL, NAPE-PLD, TRP channels, and PPARs. Discover their critical roles in human physiology and their potential for therapeutic intervention in neuropsychiatric, metabolic, and neurological disorders.